Amneal Pharmaceuticals, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Amneal Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $282.03 million for the year ending 2025.

  • Amneal Pharmaceuticals, Inc. showed an increase of +155.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Amneal Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2016 to 2025), Amneal Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 930.5%.
  • Historical annual values: Fiscal year 2025: $282.03 million | Fiscal year 2024: $110.55 million | Fiscal year 2023: $91.54 million | Fiscal year 2022: $25.98 million | Fiscal year 2021: $247.79 million | Fiscal year 2020: $341.38 million | Fiscal year 2019: $151.20 million | Fiscal year 2018: $213.39 million | Fiscal year 2017: $74.17 million | Fiscal year 2017: $0.00 | Fiscal year 2016: $27.37 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: